 | • レポートコード：B-GIR09D3779 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、アンチトロンビン拮抗薬の世界市場について調べ、まとめました。種類別セグメントは、プロトロンビン複合体濃縮物（PCC）、ビタミンK、プロタミン、トラネキサム酸、イダルシズマブ、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。アンチトロンビン拮抗薬の世界市場概観、企業動向、企業別アンチトロンビン拮抗薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・アンチトロンビン拮抗薬の市場概観 ・アンチトロンビン拮抗薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・アンチトロンビン拮抗薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・アンチトロンビン拮抗薬の世界市場規模 ・アンチトロンビン拮抗薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・アンチトロンビン拮抗薬のアメリカ市場規模推移 ・アンチトロンビン拮抗薬のカナダ市場規模推移 ・アンチトロンビン拮抗薬のメキシコ市場規模推移 ・アンチトロンビン拮抗薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・アンチトロンビン拮抗薬のドイツ市場規模推移 ・アンチトロンビン拮抗薬のイギリス市場規模推移 ・アンチトロンビン拮抗薬のロシア市場規模推移 ・アンチトロンビン拮抗薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・アンチトロンビン拮抗薬の日本市場規模推移 ・アンチトロンビン拮抗薬の中国市場規模推移 ・アンチトロンビン拮抗薬の韓国市場規模推移 ・アンチトロンビン拮抗薬のインド市場規模推移 ・アンチトロンビン拮抗薬の東南アジア市場規模推移 ・アンチトロンビン拮抗薬の南米市場分析（ブラジル、アルゼンチン等） ・アンチトロンビン拮抗薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・アンチトロンビン拮抗薬の種類別分析/販売量、売上、市場シェア（プロトロンビン複合体濃縮物（PCC）、ビタミンK、プロタミン、トラネキサム酸、イダルシズマブ、その他） ・アンチトロンビン拮抗薬の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局） ・アンチトロンビン拮抗薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・アンチトロンビン拮抗薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
North America and Europe, cumulatively, accounted for over 70% share of the global market in 2018.
The global Anticoagulant Reversal Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Anticoagulant Reversal Drugs.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Anticoagulant Reversal Drugs market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Anticoagulant Reversal Drugs market by product type and applications/end industries.
Market Segment by Companies, this report covers
Pfizer
Bausch Health Companies
Fresenius
Boehringer Ingelheim
Amneal Pharmaceuticals
CSL Limited
Octapharma AG
Portola Pharmaceuticals
AMAG Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Prothrombin Complex Concentrates (PCC)
Vitamin K
Protamine
Tranexamic Acid
Idarucizumab
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Table of Contents
1 Anticoagulant Reversal Drugs Market Overview
1.1 Product Overview and Scope of Anticoagulant Reversal Drugs
1.2 Classification of Anticoagulant Reversal Drugs by Types
1.2.1 Global Anticoagulant Reversal Drugs Revenue Comparison by Types (2019-2024)
1.2.2 Global Anticoagulant Reversal Drugs Revenue Market Share by Types in 2018
1.2.3 Prothrombin Complex Concentrates (PCC)
1.2.4 Vitamin K
1.2.5 Protamine
1.2.6 Tranexamic Acid
1.2.7 Idarucizumab
1.2.8 Others
1.3 Global Anticoagulant Reversal Drugs Market by Application
1.3.1 Global Anticoagulant Reversal Drugs Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Anticoagulant Reversal Drugs Market by Regions
1.4.1 Global Anticoagulant Reversal Drugs Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Anticoagulant Reversal Drugs Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Anticoagulant Reversal Drugs Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anticoagulant Reversal Drugs Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Anticoagulant Reversal Drugs Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anticoagulant Reversal Drugs Status and Prospect (2014-2024)
1.5 Global Market Size of Anticoagulant Reversal Drugs (2014-2024)
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Anticoagulant Reversal Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bausch Health Companies
2.2.1 Business Overview
2.2.2 Anticoagulant Reversal Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bausch Health Companies Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.3 Fresenius
2.3.1 Business Overview
2.3.2 Anticoagulant Reversal Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Fresenius Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.4 Boehringer Ingelheim
2.4.1 Business Overview
2.4.2 Anticoagulant Reversal Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Boehringer Ingelheim Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.5 Amneal Pharmaceuticals
2.5.1 Business Overview
2.5.2 Anticoagulant Reversal Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Amneal Pharmaceuticals Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.6 CSL Limited
2.6.1 Business Overview
2.6.2 Anticoagulant Reversal Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 CSL Limited Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.7 Octapharma AG
2.7.1 Business Overview
2.7.2 Anticoagulant Reversal Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Octapharma AG Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.8 Portola Pharmaceuticals
2.8.1 Business Overview
2.8.2 Anticoagulant Reversal Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Portola Pharmaceuticals Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
2.9 AMAG Pharmaceuticals
2.9.1 Business Overview
2.9.2 Anticoagulant Reversal Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AMAG Pharmaceuticals Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
3 Global Anticoagulant Reversal Drugs Market Competition, by Players
3.1 Global Anticoagulant Reversal Drugs Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Anticoagulant Reversal Drugs Players Market Share
3.2.2 Top 10 Anticoagulant Reversal Drugs Players Market Share
3.3 Market Competition Trend
4 Global Anticoagulant Reversal Drugs Market Size by Regions
4.1 Global Anticoagulant Reversal Drugs Revenue and Market Share by Regions
4.2 North America Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
4.3 Europe Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
4.5 South America Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
5 North America Anticoagulant Reversal Drugs Revenue by Countries
5.1 North America Anticoagulant Reversal Drugs Revenue by Countries (2014-2019)
5.2 USA Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
5.3 Canada Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
5.4 Mexico Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
6 Europe Anticoagulant Reversal Drugs Revenue by Countries
6.1 Europe Anticoagulant Reversal Drugs Revenue by Countries (2014-2019)
6.2 Germany Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
6.3 UK Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
6.4 France Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
6.5 Russia Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
6.6 Italy Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Anticoagulant Reversal Drugs Revenue by Countries
7.1 Asia-Pacific Anticoagulant Reversal Drugs Revenue by Countries (2014-2019)
7.2 China Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
7.3 Japan Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
7.4 Korea Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
7.5 India Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
8 South America Anticoagulant Reversal Drugs Revenue by Countries
8.1 South America Anticoagulant Reversal Drugs Revenue by Countries (2014-2019)
8.2 Brazil Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
8.3 Argentina Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
8.4 Colombia Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Anticoagulant Reversal Drugs by Countries
9.1 Middle East and Africa Anticoagulant Reversal Drugs Revenue by Countries (2014-2019)
9.2 Saudi Arabia Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
9.3 UAE Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
9.4 Egypt Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
9.5 Nigeria Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
9.6 South Africa Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
10 Global Anticoagulant Reversal Drugs Market Segment by Type
10.1 Global Anticoagulant Reversal Drugs Revenue and Market Share by Type (2014-2019)
10.2 Global Anticoagulant Reversal Drugs Market Forecast by Type (2019-2024)
10.3 Prothrombin Complex Concentrates (PCC) Revenue Growth Rate (2014-2024)
10.4 Vitamin K Revenue Growth Rate (2014-2024)
10.5 Protamine Revenue Growth Rate (2014-2024)
10.6 Tranexamic Acid Revenue Growth Rate (2014-2024)
10.7 Idarucizumab Revenue Growth Rate (2014-2024)
10.8 Others Revenue Growth Rate (2014-2024)
11 Global Anticoagulant Reversal Drugs Market Segment by Application
11.1 Global Anticoagulant Reversal Drugs Revenue Market Share by Application (2014-2019)
11.2 Anticoagulant Reversal Drugs Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Anticoagulant Reversal Drugs Market Size Forecast (2019-2024)
12.1 Global Anticoagulant Reversal Drugs Market Size Forecast (2019-2024)
12.2 Global Anticoagulant Reversal Drugs Market Forecast by Regions (2019-2024)
12.3 North America Anticoagulant Reversal Drugs Revenue Market Forecast (2019-2024)
12.4 Europe Anticoagulant Reversal Drugs Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Anticoagulant Reversal Drugs Revenue Market Forecast (2019-2024)
12.6 South America Anticoagulant Reversal Drugs Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Anticoagulant Reversal Drugs Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Anticoagulant Reversal Drugs Picture
Table Product Specifications of Anticoagulant Reversal Drugs
Table Global Anticoagulant Reversal Drugs and Revenue (Million USD) Market Split by Product Type
Figure Global Anticoagulant Reversal Drugs Revenue Market Share by Types in 2018
Figure Prothrombin Complex Concentrates (PCC) Picture
Figure Vitamin K Picture
Figure Protamine Picture
Figure Tranexamic Acid Picture
Figure Idarucizumab Picture
Figure Others Picture
Table Global Anticoagulant Reversal Drugs Revenue (Million USD) by Application (2014-2024)
Figure Anticoagulant Reversal Drugs Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Anticoagulant Reversal Drugs Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Anticoagulant Reversal Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Anticoagulant Reversal Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Anticoagulant Reversal Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Anticoagulant Reversal Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Anticoagulant Reversal Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Anticoagulant Reversal Drugs Revenue (Million USD) and Growth Rate (2014-2024)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Anticoagulant Reversal Drugs Type and Applications
Table Pfizer Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Companies Basic Information, Manufacturing Base and Competitors
Table Bausch Health Companies Anticoagulant Reversal Drugs Type and Applications
Table Bausch Health Companies Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Fresenius Basic Information, Manufacturing Base and Competitors
Table Fresenius Anticoagulant Reversal Drugs Type and Applications
Table Fresenius Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer Ingelheim Anticoagulant Reversal Drugs Type and Applications
Table Boehringer Ingelheim Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Amneal Pharmaceuticals Anticoagulant Reversal Drugs Type and Applications
Table Amneal Pharmaceuticals Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table CSL Limited Basic Information, Manufacturing Base and Competitors
Table CSL Limited Anticoagulant Reversal Drugs Type and Applications
Table CSL Limited Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Octapharma AG Basic Information, Manufacturing Base and Competitors
Table Octapharma AG Anticoagulant Reversal Drugs Type and Applications
Table Octapharma AG Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Portola Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Portola Pharmaceuticals Anticoagulant Reversal Drugs Type and Applications
Table Portola Pharmaceuticals Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table AMAG Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table AMAG Pharmaceuticals Anticoagulant Reversal Drugs Type and Applications
Table AMAG Pharmaceuticals Anticoagulant Reversal Drugs Revenue, Gross Margin and Market Share (2017-2018)
Table Global Anticoagulant Reversal Drugs Revenue (Million USD) by Players (2014-2019)
Table Global Anticoagulant Reversal Drugs Revenue Share by Players (2014-2019)
Figure Global Anticoagulant Reversal Drugs Revenue Share by Players in 2017
Figure Global Anticoagulant Reversal Drugs Revenue Share by Players in 2018
Figure Global Top 5 Players Anticoagulant Reversal Drugs Revenue Market Share in 2018
Figure Global Top 10 Players Anticoagulant Reversal Drugs Revenue Market Share in 2018
Figure Global Anticoagulant Reversal Drugs Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Anticoagulant Reversal Drugs Revenue (Million USD) by Regions (2014-2019)
Table Global Anticoagulant Reversal Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Anticoagulant Reversal Drugs Revenue Market Share by Regions (2014-2019)
Figure Global Anticoagulant Reversal Drugs Revenue Market Share by Regions in 2018
Figure North America Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Europe Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure South America Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Table North America Anticoagulant Reversal Drugs Revenue by Countries (2014-2019)
Table North America Anticoagulant Reversal Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Anticoagulant Reversal Drugs Revenue Market Share by Countries (2014-2019)
Figure North America Anticoagulant Reversal Drugs Revenue Market Share by Countries in 2018
Figure USA Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Canada Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Mexico Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Table Europe Anticoagulant Reversal Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Europe Anticoagulant Reversal Drugs Revenue Market Share by Countries (2014-2019)
Figure Europe Anticoagulant Reversal Drugs Revenue Market Share by Countries in 2018
Figure Germany Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure UK Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure France Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Russia Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Italy Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Anticoagulant Reversal Drugs Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Anticoagulant Reversal Drugs Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Anticoagulant Reversal Drugs Revenue Market Share by Countries in 2018
Figure China Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Japan Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Korea Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure India Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Table South America Anticoagulant Reversal Drugs Revenue by Countries (2014-2019)
Table South America Anticoagulant Reversal Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Anticoagulant Reversal Drugs Revenue Market Share by Countries (2014-2019)
Figure South America Anticoagulant Reversal Drugs Revenue Market Share by Countries in 2018
Figure Brazil Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Argentina Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Colombia Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Anticoagulant Reversal Drugs Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Anticoagulant Reversal Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anticoagulant Reversal Drugs Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Anticoagulant Reversal Drugs Revenue Market Share by Countries in 2018
Figure Saudi Arabia Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure UAE Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Egypt Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure Nigeria Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Figure South Africa Anticoagulant Reversal Drugs Revenue and Growth Rate (2014-2019)
Table Global Anticoagulant Reversal Drugs Revenue (Million USD) by Type (2014-2019)
Table Global Anticoagulant Reversal Drugs Revenue Share by Type (2014-2019)
Figure Global Anticoagulant Reversal Drugs Revenue Share by Type (2014-2019)
Figure Global Anticoagulant Reversal Drugs Revenue Share by Type in 2019
Table Global Anticoagulant Reversal Drugs Revenue Forecast by Type (2019-2024)
Figure Global Anticoagulant Reversal Drugs Market Share Forecast by Type (2019-2024)
Figure Global Prothrombin Complex Concentrates (PCC) Revenue Growth Rate (2014-2019)
Figure Global Vitamin K Revenue Growth Rate (2014-2019)
Figure Global Protamine Revenue Growth Rate (2014-2019)
Figure Global Tranexamic Acid Revenue Growth Rate (2014-2019)
Figure Global Idarucizumab Revenue Growth Rate (2014-2019)
Figure Global Others Revenue Growth Rate (2014-2019)
Table Global Anticoagulant Reversal Drugs Revenue by Application (2014-2019)
Table Global Anticoagulant Reversal Drugs Revenue Share by Application (2014-2019)
Figure Global Anticoagulant Reversal Drugs Revenue Share by Application (2014-2019)
Figure Global Anticoagulant Reversal Drugs Revenue Share by Application in 2019
Table Global Anticoagulant Reversal Drugs Revenue Forecast by Application (2019-2024)
Figure Global Anticoagulant Reversal Drugs Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Anticoagulant Reversal Drugs Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Anticoagulant Reversal Drugs Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Anticoagulant Reversal Drugs Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Anticoagulant Reversal Drugs Revenue Market Forecast (2019-2024)
Figure Europe Anticoagulant Reversal Drugs Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Anticoagulant Reversal Drugs Revenue Market Forecast (2019-2024)
Figure South America Anticoagulant Reversal Drugs Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Anticoagulant Reversal Drugs Revenue Market Forecast (2019-2024)
世界のアンチトロンビン拮抗薬市場予測（～2024年） Anticoagulant reversal drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. Scope of the Report: Asia Pacific is anticipated to dominate the global market over the forecast period ow…- 世界の抗凝固薬市場予測（～2024年） Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. Scope of the Report: The worldwide market for Anticoagulant Drugs is expected to grow at a CAGR of roughly 5.0% over the next five years, will r…
- 世界のボツリヌス中毒症薬市場予測（～2024年） Botulism is a rare and potentially fatal illness caused by a toxin produced by the bacterium Clostridium botulinum. The disease begins with weakness, blurred vision, feeling tired, and trouble speaking. This may then be followed by weakness of the arms, chest muscles, and legs. Vomiting, swelling of…
- 世界のホジキンリンパ腫薬市場予測（～2024年） Hodgkin's lymphoma is a type of lymphoma in which cancer originates from a specific type of white blood cells called lymphocytes. Symptoms may include fever, night sweats, and weight loss. Often there will be non-painful enlarged lymph nodes in the neck, under the arm, or in the groin. Those affecte…
- 世界の凍結乾燥注射薬市場予測（～2024年） Scope of the Report: Based on type of packaging, the single-use vials segment is anticipated held major market share in 2018 and the trend is projected to continue during the forecast period. The global Lyophilized Injectable Drugs market is valued at xx million USD in 2018 and is expected to reach …